These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 11701067)
21. Combination nonviral cytokine gene therapy for head and neck cancer. Li D; Zeiders JW; Liu S; Guo M; Xu Y; Bishop JS; O'Malley BW Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072 [TBL] [Abstract][Full Text] [Related]
22. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer. Bray D; Yu SZ; Koprowski H; Rhee J; Kumar S; Pericle F; Suntharalingam M; Van Echo DA; Li D; O'Malley BW Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):618-22. PubMed ID: 12810463 [TBL] [Abstract][Full Text] [Related]
23. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
24. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model]. Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865 [TBL] [Abstract][Full Text] [Related]
25. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma. Liu S; Yang H; Liang C Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755 [TBL] [Abstract][Full Text] [Related]
26. Antitumor activities of IL-12 and mechanisms of action. Shurin MR; Esche C; Péron JM; Lotze MT Chem Immunol; 1997; 68():153-74. PubMed ID: 9329221 [No Abstract] [Full Text] [Related]
27. Cancer electrogene therapy with interleukin-12. Cemazar M; Jarm T; Sersa G Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875 [TBL] [Abstract][Full Text] [Related]
29. IL-12: a key cytokine in immune regulation. Lamont AG; Adorini L Immunol Today; 1996 May; 17(5):214-7. PubMed ID: 8991382 [TBL] [Abstract][Full Text] [Related]
30. Role of IL12 as an anti-tumour agent: current status and future directions. Brunda MJ Res Immunol; 1995; 146(7-8):622-28. PubMed ID: 8839170 [No Abstract] [Full Text] [Related]
32. Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical application. Zitvogel L; Lotze MT Res Immunol; 1995; 146(7-8):628-38. PubMed ID: 8839171 [No Abstract] [Full Text] [Related]
33. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Li D; Shugert E; Guo M; Bishop JS; O'Malley BW Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067 [TBL] [Abstract][Full Text] [Related]
34. The use of biological therapy in cancer of the head and neck. Myers JN Curr Probl Cancer; 1999; 23(3):106-34. PubMed ID: 10397386 [TBL] [Abstract][Full Text] [Related]
35. Electroporation gene therapy preclinical and clinical trials for melanoma. Heller LC; Heller R Curr Gene Ther; 2010 Aug; 10(4):312-7. PubMed ID: 20557286 [TBL] [Abstract][Full Text] [Related]
36. Injectable modalities as local and regional strategies for head and neck cancer. Clayman GL; Dreiling LK Hematol Oncol Clin North Am; 1999 Aug; 13(4):787-810, viii. PubMed ID: 10494514 [TBL] [Abstract][Full Text] [Related]